These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25833208)

  • 21. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
    Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S
    J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
    Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
    Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.
    Conley SJ; Gheordunescu E; Kakarala P; Newman B; Korkaya H; Heath AN; Clouthier SG; Wicha MS
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2784-9. PubMed ID: 22308314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
    Rapisarda A; Hollingshead M; Uranchimeg B; Bonomi CA; Borgel SD; Carter JP; Gehrs B; Raffeld M; Kinders RJ; Parchment R; Anver MR; Shoemaker RH; Melillo G
    Mol Cancer Ther; 2009 Jul; 8(7):1867-77. PubMed ID: 19584228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antioxidant N-acetylcysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo.
    Sceneay J; Liu MC; Chen A; Wong CS; Bowtell DD; Möller A
    PLoS One; 2013; 8(6):e66388. PubMed ID: 23840457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
    Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
    Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
    [No Abstract]   [Full Text] [Related]  

  • 30. Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy.
    Sun X; Vale M; Jiang X; Gupta R; Krissansen GW
    Cancer Gene Ther; 2010 Aug; 17(8):532-40. PubMed ID: 20348876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
    Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
    Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Chandra A; Jahangiri A; Chen W; Nguyen AT; Yagnik G; Pereira MP; Jain S; Garcia JH; Shah SS; Wadhwa H; Joshi RS; Weiss J; Wolf KJ; Lin JG; Müller S; Rick JW; Diaz AA; Gilbert LA; Kumar S; Aghi MK
    Cancer Res; 2020 Apr; 80(7):1498-1511. PubMed ID: 32041837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
    Chen H; Guan Y; Yuan G; Zhang Q; Jing N
    Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
    Kerbel RS; Guerin E; Francia G; Xu P; Lee CR; Ebos JM; Man S
    Breast; 2013 Aug; 22 Suppl 2():S57-65. PubMed ID: 24074794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing.
    Clark AJ; Wiley DT; Zuckerman JE; Webster P; Chao J; Lin J; Yen Y; Davis ME
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3850-4. PubMed ID: 27001839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
    Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
    Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
    Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.
    Liu Y; Chen C; Qian P; Lu X; Sun B; Zhang X; Wang L; Gao X; Li H; Chen Z; Tang J; Zhang W; Dong J; Bai R; Lobie PE; Wu Q; Liu S; Zhang H; Zhao F; Wicha MS; Zhu T; Zhao Y
    Nat Commun; 2015 Jan; 6():5988. PubMed ID: 25612916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.
    Liao D; Corle C; Seagroves TN; Johnson RS
    Cancer Res; 2007 Jan; 67(2):563-72. PubMed ID: 17234764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.